Filing Details
- Accession Number:
- 0001104659-25-075801
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-08 20:00:15
- Reporting Period:
- 2025-08-06
- Filing Date:
- 2025-08-08
- Accepted Time:
- 2025-08-08 20:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1974640 | Apogee Therapeutics Inc. | APGE | Biological Products, (No Disgnostic Substances) (2836) | 934958665 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1983476 | Carl Dambkowski | C/O Apogee Therapeutics, Inc. 221 Crescent St., Bldg. 17, Ste. 102B Waltham MA 02453 | Chief Medical Officer | No | Yes | No | No |
Transaction Summary
| Sold: | 2,725 shares | Avg. Price: $37.78 | Total Value: $102,950.50 |
| Number of Shares After Transactions: | 236,273 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-08-06 | 2,725 | $37.78 | 236,273 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024.
Billionaire Hedge Funds
